Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Seider

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Retina (Philadelphia, Pa.)|March 27, 2018
RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional StudyDuncan Berry, Michael Seider, Sandra Stinnett, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|September 24, 2009
Ultra-high resolution spectral domain optical coherence tomography of traumatic maculopathyMichael I Seider, Michael Seider, Brandon J Lujan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactionsColleen A Lawton, Michelle DeSilvio, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
Cancers|June 26, 2025
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam RadiationCarly Zako, Arina Nisanova, Vivian Weinberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Retina (Philadelphia, Pa.)|March 27, 2018
RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional StudyDuncan Berry, Michael Seider, Sandra Stinnett, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|September 24, 2009
Ultra-high resolution spectral domain optical coherence tomography of traumatic maculopathyMichael I Seider, Michael Seider, Brandon J Lujan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactionsColleen A Lawton, Michelle DeSilvio, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
Cancers|June 26, 2025
Long-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam RadiationCarly Zako, Arina Nisanova, Vivian Weinberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Pageof 1